Key Takeaways OPRX Q1 revenues rose 11% YoY to $21.9M with $1.5M adjusted EBITDA and raised FY25 guidance. OPRX's DAAP and subscription model drive margin gains, with 80% of FY25 revenues under contract. OPRX cut OpEx by $5M and targets Rule of 40 status, but gross margin dipped on managed services mix.OptimizeRx (OPRX) is making a bold shift toward AI-driven, workflow-integrated solutions, signaling a strategic evolution that could redefine its role in digital pharma communications. On its first-quarter ...